FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Walter Vervenne

Research Profile

Disorders

Esophageal Neoplasms

Chemicals & Drugs

Procedures

Concepts & Ideas

Physiology

Drug Antagonism

Genes & Molecular Sequences

Genes, ras

Anatomy

Co-author Network

Publications

TOP 3
Marinke Westerterp; Marja A Boermeester; Jikke M T Omloo; Maarten C C M Hulshof; Walter L Vervenne; Rene Lutter; Theo A Out; J J B van Lanschot
Differential responses of cellular immunity in patients undergoing neoadjuvant therapy followed by surgery for carcinoma of the oesophagus.
C Dickhoff; R J Leguit; J F M Slors; Walter L Vervenne; W A Bemelman
Giant rectal gastrointestinal stromal tumors: a report of two cases.
Wandena S Siegel-Lakhai; Jos H Beijnen; Walter L Vervenne; Henk Boot; Marianne Keessen; Melissa Versola; Kevin M Koch; Deborah A Smith; Lini Pandite; Dick J Richel; Jan H M Schellens
Phase I pharmacokinetic study of the safety and tolerability of lapatinib (GW572016) in combination with oxaliplatin/fluorouracil/leucovorin (FOLFOX4) in patients with solid tumors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Walter Vervenne (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Marinke Westerterp; Marja A Boermeester; Jikke M T Omloo; Maarten C C M Hulshof; Walter L Vervenne; Rene Lutter; Theo A Out; J J B van Lanschot
Differential responses of cellular immunity in patients undergoing neoadjuvant therapy followed by surgery for carcinoma of the oesophagus.
Cancer immunology, immunotherapy : CII 2008;57(12):1837-47.
2008: C Dickhoff; R J Leguit; J F M Slors; Walter L Vervenne; W A Bemelman
Giant rectal gastrointestinal stromal tumors: a report of two cases.
Case reports in gastroenterology 2008;2(1):54-69.
2007: Wandena S Siegel-Lakhai; Jos H Beijnen; Walter L Vervenne; Henk Boot; Marianne Keessen; Melissa Versola; Kevin M Koch; Deborah A Smith; Lini Pandite; Dick J Richel; Jan H M Schellens
Phase I pharmacokinetic study of the safety and tolerability of lapatinib (GW572016) in combination with oxaliplatin/fluorouracil/leucovorin (FOLFOX4) in patients with solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(15 Pt 1):4495-502.
2006: Maarten L Janmaat; Mariëlle I Gallegos-Ruiz; Jose A Rodriguez; Gerrit A Meijer; Walter L Vervenne; Dick J Richel; Cees Van Groeningen; Giuseppe Giaccone
Predictive factors for outcome in a phase II study of gefitinib in second-line treatment of advanced esophageal cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(10):1612-9.
2004: Dick J Richel; Walter L Vervenne
Systemic treatment of oesophageal cancer.
European journal of gastroenterology & hepatology 2004;16(3):249-54.
2002: Walter L Vervenne; Carina L Bos; Linda S Rens; Maikel Peppelenbosch; Dick J Richel
Farnesyl protein transferase inhibition interferes with activation of MAP kinase family members in human peripheral blood monocytes.
Molecular medicine (Cambridge, Mass.) 2002;8(12):857-62.